Baxter Spectrum IQ Infusion Pump Recall Issued Due To Software Defects

Federal health officials have announced a recall of certain Baxter Spectrum IQ infusion pumps, after the manufacturer warned the devices may experience software defects that cause the pump to suddenly stop delivery critical fluids to patients, potentially resulting in serious and life threatening injuries.

The Baxter Spectrum IQ recall was announced by the U.S. Food and Drug Administration (FDA) on August 24, following two reports of the infusion pumps suddenly failing, after customers made changes to the configuration of their network and server systems.

The Spectrum IQ is an infusion pump used to deliver medications, blood, and blood products into a patient’s body in a controlled manner. The recalled infusion pumps include a “version 9.0” software, which allows care providers to create a drug library of pre-programmed dosing information for specific medications. However, it now appears that a software defect in the infusion pump may lead to mismatched drug information in the libraries when customers make changes to their network configurations.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

Officials are warning the pumps could experience connectivity errors that place stress on the pumps processor when network configuration changes are being made. During such an this event, a “watchdog” system error alarm may activate, indicating the pump has entered a fail-safe mode, which may cause serious adverse health consequences or death depending on the length of delay, medication being infused, the volume and rate of the infusion, patient health condition and comorbidities.

The recall includes the Spectrum IQ Infusion System with Dose IQ Safety Software marked with Product Code: 3570009. The devices were manufactured by Baxter International Inc. of Deerfield, Illinois and were distributed to hospitals and medical facilities across the U.S. from February 1, 2018 to January 1, 2019

Baxter International issued an Urgent Device Correction on August 2, warning customers to contact Baxter Technical Assistance at 800-356-3454 in advance of making changes to their network or server infrastructure supporting the pumps or the Baxter Gateway to reduce the likelihood of encountering an issue.

Clinicians are being instructed to immediately power cycle the device if the watchdog system error occurs and to ensure backup devices are readily available when infusing critical medications where interruptions could cause serious injury or death.

The manufacturer announced it is developing a software upgrade for all Spectrum IQ infusion pumps that will assist how the pump responds to unstable network and server systems by reducing the stress on the pump’s memory and processing functions if this occurs.

According to Baxter, the software upgrade is expected to be available by the fourth quarter of 2021, and the manufacturer will notify customers and work with them to schedule the upgrades.

Customers with questions concerning the recall are encouraged to contact Baxter sales representative or Baxter Technical Assistance at 800-356-3454. Any and all adverse events should be reported immediately to Baxter Product Surveillance at 800-437-5176 or to the FDA MedWatch Adverse Event Reporting Program.


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

AT&T Data Breach Class Action Claims Telecom Giant
AT&T Data Breach Class Action Claims Telecom Giant "Disregarded" Customer Financial Safety (Posted today)

A Missouri woman is one of the latest person to file an class action claim over the AT&T data breach, after the telecom company admitted that hackers stole millions of customers' personal information and sold it on the internet.

Plaintiffs Oppose Phased Discovery Over Suboxone Tooth Decay Risks in MDL
Plaintiffs Oppose Phased Discovery Over Suboxone Tooth Decay Risks in MDL (Posted yesterday)

Plaintiffs say a federal judge should not waste time on a phased discovery plan requiring them to first prove Suboxone strips can cause tooth decay, saying the science is obvious and such a plan could delay resolution of hundreds of product liability lawsuits.